Evaluation of a HiRes™ Optima Sound Processing Strategy for the HiResolution™ Bionic Ear (NCT01616576) | Clinical Trial Compass
CompletedNot Applicable
Evaluation of a HiRes™ Optima Sound Processing Strategy for the HiResolution™ Bionic Ear
United States36 participantsStarted 2012-05
Plain-language summary
The purpose of this study is to compare a new sound processing strategy to the current sound processing strategy.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Unilateral or bilateral user of CII/HiRes90K™ implant(s) (minimum of one year in each implanted ear), Harmony™ BTE processor(s) with HiRes Fidelity 120™ (with or without ClearVoice™) as preferred sound processing strategy
* 18 years of age or older at time of implant
* Postlingual onset of severe-to-profound hearing loss (≥ 6 years of age)
* At least moderate open-set speech recognition abilities (defined as CNC word score ≥ 50% in medical records or assessed at the Baseline Visit with implant alone for unilateral users, with both implants together for bilateral users)
* English language proficiency
* Willingness to use a Harmony™ BTE processor and refrain from ClearVoice™ use for the duration of the study
* Willingness and ability to participate in all scheduled procedures outlined in the protocol
Exclusion Criteria:
• Presence of any additional disabilities that would prevent or interfere with participation in the required speech perception testing
What they're measuring
1
Speech Perception With Control and Experimental Conditions Both Tested in Quiet, in Speech-spectrum Noise, and in Multi-talker Babble Noise.